Deal Announcements

CeNeRx Reports $3 Million New VC Funding

Thursday, August 12, 2010 5:37:00 AM PDT | VentureDeal Staff

Cary, North Carolina  --  Biotechnology company CeNeRx BioPharma has raised $3 million in new venture capital investment, according to an SEC regulatory filing.

CeNeRx is a clinical stage company that is developing improved treatments for diseases of the central nervous system.

Investors in the new financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1